Angina pectoris
Conditions
Interventions
control group:placebo
Sponsors
Shanghai Municipal Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. According to the diagnostic criteria of Western medicine for coronary heart disease (one of the following criteria is met): (1) he has received coronary revascularization therapy, including percutaneous coronary intervention and coronary artery bypass grafting; (2) coronary angiography or coronary CT angiography results show that at least one coronary artery is narrow and the lumen stenosis is more than 50%; (3) The patients were diagnosed as coronary heart disease and myocardial ischemia by dynamic or static or drug loading radionuclide myocardial scanning; (4) having a clear history of myocardial infarction in the past. (Note: the results of one of the above four items provided by the tertiary hospital can be used as diagnostic evidence, and the copy is attached to the research medical record.) 2. The results showed that the patients met the diagnostic criteria of Western medicine for stable angina pectoris; 3. they met the syndrome differentiation criteria of qi deficiency and blood stasis in traditional Chinese medicine; 4. outpatients or inpatients aged between 18 and 70 years old (including boundary value); 5. patients of childbearing age agreed to use a medically acceptable non drug measure for contraception or abstinence within 3 months after the last medication; 6. Patients understand and follow the research process, which is sufficient to complete all the tests and examinations required by the protocol, communicate well with the researchers, participate in the trial voluntarily, and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. patients with cardiac function grade 3-4 or pulmonary edema; 2. patients with severe primary brain and lung diseases and liver and kidney dysfunction; 3. patients with traditional Chinese medicine allergy; 4. patients with malignant diseases; 5. patients with severe inflammatory diseases; 6. patients with hemorrhagic diseases; 7. malignant arrhythmias; 8. acute coronary syndrome; 9. critical severe hypertension; 10. psychiatric patients; 11. pregnant or lactating women; 12. nearly 1 Participants in other clinical trials within months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Noninvasive hemodynamic detection;Colour Sonography;electrocardiogram; | — |
Countries
China
Contacts
Public ContactWengjiahao
Shanghai Municipal Hospital of Traditional Chinese Medicine
Outcome results
None listed